223 related articles for article (PubMed ID: 29452653)
1. [Post-inflammatory hyperpigmentation].
Passeron T
Ann Dermatol Venereol; 2016 Dec; 143 Suppl 2():S15-S19. PubMed ID: 29452653
[TBL] [Abstract][Full Text] [Related]
2. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians.
Cheyasak N; Manuskiatti W; Maneeprasopchoke P; Wanitphakdeedecha R
Acta Derm Venereol; 2015 Feb; 95(2):201-5. PubMed ID: 24854088
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo].
Cardinali G; Kovacs D; Picardo M
Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S96-101. PubMed ID: 23260525
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of Post-Inflammatory Hyperpigmentation From Energy-Based Device Treatments: A Review [Formula: see text].
Wong ITY; Richer V
J Cutan Med Surg; 2021; 25(1):77-86. PubMed ID: 32929988
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo.
Cardinali G; Kovacs D; Picardo M
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S148-52. PubMed ID: 23522630
[TBL] [Abstract][Full Text] [Related]
6. Postinflammatory hyperpigmentation secondary to external insult: an overview of the quantitative analysis of pigmentation.
Lamel SA; Rahvar M; Maibach HI
Cutan Ocul Toxicol; 2013 Mar; 32(1):67-71. PubMed ID: 22667459
[TBL] [Abstract][Full Text] [Related]
7. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention.
Chaowattanapanit S; Silpa-Archa N; Kohli I; Lim HW; Hamzavi I
J Am Acad Dermatol; 2017 Oct; 77(4):607-621. PubMed ID: 28917452
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians.
Chan HH; Manstein D; Yu CS; Shek S; Kono T; Wei WI
Lasers Surg Med; 2007 Jun; 39(5):381-5. PubMed ID: 17518354
[TBL] [Abstract][Full Text] [Related]
9. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
Callender VD; St Surin-Lord S; Davis EC; Maclin M
Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a wound-dressing biomaterial on prevention of postinflammatory hyperpigmentation after suction blister epidermal grafting in stable vitiligo patients: a controlled assessor-blinded clinical study with in vitro bioactivity investigation.
Liu Z; Jiang M; Zhao J; Wang Q; Zhang C; Gao M; Gu M; Xiang L
Arch Dermatol Res; 2020 Nov; 312(9):635-645. PubMed ID: 32107629
[TBL] [Abstract][Full Text] [Related]
11. Postinflammatory hyperpigmentation: A comprehensive overview: Epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique.
Silpa-Archa N; Kohli I; Chaowattanapanit S; Lim HW; Hamzavi I
J Am Acad Dermatol; 2017 Oct; 77(4):591-605. PubMed ID: 28917451
[TBL] [Abstract][Full Text] [Related]
12. [Post-inflammatory hyperpigmentation occuring after cosmetic procedures].
Beylot C; Raimbault-Gerard C
Ann Dermatol Venereol; 2016 Dec; 143 Suppl 2():S33-S42. PubMed ID: 29452657
[TBL] [Abstract][Full Text] [Related]
13. Postinflammatory hyperpigmentation.
Taylor S; Grimes P; Lim J; Im S; Lui H
J Cutan Med Surg; 2009; 13(4):183-91. PubMed ID: 19706225
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a new UVA protection factor: use of an in vitro model of immediate pigment darkening.
Routaboul C; Denis A; Bohbot M
Eur J Dermatol; 2002; 12(5):439-44. PubMed ID: 12370130
[TBL] [Abstract][Full Text] [Related]
16. The use of sunscreen starting on the first day after ablative fractional skin resurfacing.
Wanitphakdeedecha R; Phuardchantuk R; Manuskiatti W
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1522-8. PubMed ID: 24320057
[TBL] [Abstract][Full Text] [Related]
17. Influence of visible light on cutaneous hyperchromias: Clinical efficacy of broad-spectrum sunscreens.
Martini APM; Maia Campos PMBG
Photodermatol Photoimmunol Photomed; 2018 Jul; 34(4):241-248. PubMed ID: 29381828
[TBL] [Abstract][Full Text] [Related]
18. Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure.
Duteil L; Cardot-Leccia N; Queille-Roussel C; Maubert Y; Harmelin Y; Boukari F; Ambrosetti D; Lacour JP; Passeron T
Pigment Cell Melanoma Res; 2014 Sep; 27(5):822-6. PubMed ID: 24888214
[TBL] [Abstract][Full Text] [Related]
19. [How to optimize scarring in dermatologic surgery?].
Amici JM; Chaussade V
Ann Dermatol Venereol; 2016 Dec; 143 Suppl 2():S20-S25. PubMed ID: 29452655
[TBL] [Abstract][Full Text] [Related]
20. The Role of Sunscreen in Melasma and Postinflammatory Hyperpigmentation.
Fatima S; Braunberger T; Mohammad TF; Kohli I; Hamzavi IH
Indian J Dermatol; 2020; 65(1):5-10. PubMed ID: 32029932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
